OBJECTIVE: A significant proportion of breast cancer patients experience psychiatric morbidity. The present study compared the psychopathological profile (depression, anxiety and general psychopathology) of Greek women with breast cancer with a group of healthy controls. MATERIALS AND METHODS: Patients (n=109) were recruited from a specialized oncology breast cancer department and healthy controls (n=71) from a breast outpatient clinic. General psychopathology was assessed by the SCL-90-R. The Montgomery-Asberg Depression Rating Scale (MADRS) and the Spielberger State-Trait Anxiety Inventory (STAI) were used for assessing depression and anxiety. Demographics and clinical characteristics were also recorded. Data were modeled using multiple regression analysis. RESULTS: The mean age was 54.7±18.1 years for the control group and 51.2±9.5 years for the patient group (p=0.288). Mean scores on SCL-90-R, MADRS and STAI were significantly higher in the cancer group compared to controls (p<0.05). Multiple regression analysis revealed that breast cancer was independently and positively associated with all psychological measures (p<0.05). Regression coefficients ranged from 0.19 (SCL-90-R, psychotism) to 0.33 (MADRS). Lower anger/aggressiveness and anxiety were found in highly educated women; divorced/widowed women scored higher on obsessionality and MADRS compared to married women. Psychiatric treatment was associated with higher scores on somatization, depression, phobic anxiety and general psychopathology. CONCLUSION: Anxiety, depression, and overall psychopathology are more frequent in breast cancer patients compared to controls. Disease makes a larger independent contribution to all psychopathological measures than any other investigated variable. Therefore, breast cancer patients should be closely followed up in order to identify and timely treat any mental health problems that may arise.
OBJECTIVE: A significant proportion of breast cancerpatients experience psychiatric morbidity. The present study compared the psychopathological profile (depression, anxiety and general psychopathology) of Greek women with breast cancer with a group of healthy controls. MATERIALS AND METHODS:Patients (n=109) were recruited from a specialized oncology breast cancer department and healthy controls (n=71) from a breast outpatient clinic. General psychopathology was assessed by the SCL-90-R. The Montgomery-Asberg Depression Rating Scale (MADRS) and the Spielberger State-Trait Anxiety Inventory (STAI) were used for assessing depression and anxiety. Demographics and clinical characteristics were also recorded. Data were modeled using multiple regression analysis. RESULTS: The mean age was 54.7±18.1 years for the control group and 51.2±9.5 years for the patient group (p=0.288). Mean scores on SCL-90-R, MADRS and STAI were significantly higher in the cancer group compared to controls (p<0.05). Multiple regression analysis revealed that breast cancer was independently and positively associated with all psychological measures (p<0.05). Regression coefficients ranged from 0.19 (SCL-90-R, psychotism) to 0.33 (MADRS). Lower anger/aggressiveness and anxiety were found in highly educated women; divorced/widowed women scored higher on obsessionality and MADRS compared to married women. Psychiatric treatment was associated with higher scores on somatization, depression, phobic anxiety and general psychopathology. CONCLUSION:Anxiety, depression, and overall psychopathology are more frequent in breast cancerpatients compared to controls. Disease makes a larger independent contribution to all psychopathological measures than any other investigated variable. Therefore, breast cancerpatients should be closely followed up in order to identify and timely treat any mental health problems that may arise.
Authors: Deepali Pandey; Kin Lam; William Cheung; Ashraf Mahmood; Stephanie Hicks; Russell Portenoy; Jack Chen; Lara Dhingra Journal: J Immigr Minor Health Date: 2021-02-02
Authors: Salene M W Jones; Andrea Z LaCroix; Wenjun Li; Oleg Zaslavsky; Sylvia Wassertheil-Smoller; Julie Weitlauf; Gretchen A Brenes; Rami Nassir; Judith K Ockene; Graciela Caire-Juvera; Suzanne C Danhauer Journal: J Cancer Surviv Date: 2015-02-24 Impact factor: 4.442
Authors: Syarifah Maisarah Syed Alwi; Vairavan Narayanan; Nur Aishah Mohd Taib; Normah Che Din Journal: Support Care Cancer Date: 2021-11-29 Impact factor: 3.603
Authors: Mohamed A El-Hadidy; Waleed Elnahas; Mohamed Af Hegazy; Mohamed T Hafez; Basel Refky; Khaled M Abdel Wahab Journal: Breast Cancer (Dove Med Press) Date: 2012-03-06